Generalized anxiety disorder

New England Journal of Medicine

Volumn 373, Issue 21, 2015, Pages 2059-2068

  Stein, Murray B ^a,b   Sareen, Jitender ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ANTIDEPRESSANT AGENT;

ADULT; BACKACHE; CASE REPORT; DRINKING BEHAVIOR; DSM-5; EVIDENCE BASED MEDICINE; FEMALE; GENERALIZED ANXIETY DISORDER; HEADACHE; HUMAN; INSOMNIA; LIFESTYLE MODIFICATION; MARRIED WOMAN; MIDDLE AGED; MUSCLE TONE; PATIENT ASSESSMENT; PATIENT WORRY; PRIORITY JOURNAL; PSYCHOTHERAPY; QUESTIONNAIRE; REVIEW; ANXIETY DISORDERS; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; DIFFERENTIAL DIAGNOSIS; LIFESTYLE; PREVALENCE; RISK FACTOR; SLEEP INITIATION AND MAINTENANCE DISORDERS;

ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LIFE STYLE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEROTONIN AND NORADRENALINE REUPTAKE INHIBITORS; SEROTONIN UPTAKE INHIBITORS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84947764726     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp1502514     Document Type: Review

References (51)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. Arlington, VA: American Psychiatric Association, 2013.
2. Kessler RC, Wang PS. The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health 2008; 29: 115-29.
3. Mackenzie CS, Reynolds K, Chou KL, Pagura J, Sareen J. Prevalence and correlates of generalized anxiety disorder in a national sample of older adults. Am J Geriatr Psychiatry 2011; 19: 305-15.
4. Kroenke K, Spitzer RL, Williams JB, Monahan PO, Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007;146:317-25.
5. Stein MB, Roy-Byrne PP, Craske MG, et al. Functional impact and health utility of anxiety disorders in primary care outpatients. Med Care 2005; 43: 1164-70.
6. Ramsawh HJ, Chavira DA, Stein MB. Burden of anxiety disorders in pediatric medical settings: prevalence, phenomenology, and a research agenda. Arch Pedi-atr Adolesc Med 2010; 164: 965-72.
7. Chartrand H, Sareen J, Toews M, Bolton JM. Suicide attempts versus non-suicidal self-injury among individuals with anxiety disorders in a nationally representative sample. Depress Anxiety 2012; 29:172-9.
8. Zbozinek TD, Rose RD, Wolitzky-Taylor KB, et al. Diagnostic overlap of generalized anxiety disorder and major depressive disorder in a primary care sample. Depress Anxiety 2012; 29: 1065-71.
9. Sareen J, Jacobi F, Cox BJ, Belik SL, Clara I, Stein MB. Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. Arch Intern Med 2006; 166: 2109-16.
10. Robinson J, Sareen J, Cox BJ, Bolton JM. Role of self-medication in the development of comorbid anxiety and substance use disorders: a longitudinal investigation. Arch Gen Psychiatry 2011; 68: 800-7.
11. Moreno-Peral P, Conejo-Cerón S, Motrico E, et al. Risk factors for the onset of panic and generalised anxiety disorders in the general adult population: a systematic review of cohort studies. J Affect Dis-ord 2014;168:337-48.
12. Afifi TO, Mota NP, Dasiewicz P, Mac-Millan HL, Sareen J. Physical punishment and mental disorders: results from a nationally representative US sample. Pediatrics 2012;130:184-92.
13. Hettema JM, Prescott CA, Myers JM, Neale MC, Kendler KS. The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry 2005; 62: 182-9.
14. Hettema JM, Chen X, Sun C, Brown TA. Direct, indirect and pleiotropic effects of candidate genes on internalizing disorder psychopathology. Psychol Med 2015 February 23 (Epub ahead of print).
15. Gentes EL, Ruscio AM. A meta-analy-sis of the relation of intolerance of uncertainty to symptoms of generalized anxiety disorder, major depressive disorder, and obsessive-compulsive disorder. Clin Psychol Rev 2011;31:923-33.
16. Bomyea J, Ramsawh HJ, Ball TM, et al. Intolerance of uncertainty as a mediator of reductions in worry in a cognitive behavioral treatment program for generalized anxiety disorder. J Anxiety Disord 2015;33:90-4.
17. Robinson OJ, Krimsky M, Lieberman L, Allen P, Vytal K, Grillon C. Towards a mechanistic understanding of pathological anxiety: the dorsal medial prefrontal-amygdala 'aversive amplification' circuit in unmedicated generalized and social anxiety disorders. Lancet Psychiatry 2014; 1:294-302.
18. Hilbert K, Lueken U, Beesdo-Baum K. Neural structures, functioning and connectivity in Generalized Anxiety Disorder and interaction with neuroendocrine systems: a systematic review. J Affect Disord 2014;158:114-26.
19. Ball TM, Ramsawh HJ, Campbell-Sills L, Paulus MP, Stein MB. Prefrontal dysfunction during emotion regulation in generalized anxiety and panic disorders. Psychol Med 2013;43:1475-86.
20. Fonzo GA, Ramsawh HJ, Flagan TM, et al. Common and disorder-specific neural responses to emotional faces in generalised anxiety, social anxiety and panic disorders. Br J Psychiatry 2015; 206: 206-15.
21. Fonzo GA, Ramsawh HJ, Flagan TM, et al. Cognitive-behavioral therapy for generalized anxiety disorder is associated with attenuation of limbic activation to threat-related facial emotions. J Affect Disord 2014;169:76-85.
22. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166: 1092-7.
23. Reinhold JA, Rickels K. Pharmacological treatment for generalized anxiety disorder in adults: an update. Expert Opin Pharmacother 2015;16:1669-81.
24. Bereza BG, Machado M, Ravindran AV, Einarson TR. Evidence-based review of clinical outcomes of guideline-recommended pharmacotherapies for generalized anxiety disorder. Can J Psychiatry 2012;57:470-8.
25. Cuijpers P, Sijbrandij M, Koole S, Huibers M, Berking M, Andersson G. Psychological treatment of generalized anxiety disorder: a meta-analysis. Clin Psychol Rev 2014;34:130-40.
26. McHugh RK, Whitton SW, Peckham AD, Welge JA, Otto MW. Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. J Clin Psychiatry 2013; 74: 595-602.
27. Roy-Byrne P, Craske MG, Sullivan G, et al. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA 2010;303:1921-8.
28. Craske MG, Stein MB, Sullivan G, et al. Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary care. Arch Gen Psychiatry 2011; 68: 378-88.
29. Asmundson GJ, Fetzner MG, Deboer LB, Powers MB, Otto MW, Smits JA. Let's get physical: a contemporary review of the anxiolytic effects of exercise for anxiety and its disorders. Depress Anxiety 2013; 30: 362-73.
30. Wilson H, Mannix S, Oko-osi H, Revicki DA. The impact of medication on health-related quality of life in patients with generalized anxiety disorder. CNS Drugs 2015;29:29-40.
31. Ravindran LN, Stein MB. Anxiety disorders: somatic treatment. In: Sadock BJ, Sadock VA, Ruiz P, eds. Kaplan & Sadock comprehensive textbook of psychiatry. 9th ed. Philadelphia: Lippincott Williams & Wilkins, 2009: 1906-14.
32. Kapczinski F, Lima MS, Souza JS, Schmitt R. Antidepressants for generalized anxiety disorder. Cochrane Database Syst Rev 2003;2:CD003592.
33. Roest AM, de Jonge P, Williams CD, de Vries YA, Schoevers RA, Turner EH. Reporting bias in clinical trials investigating the efficacy of second-generation antidepressants in the treatment of anxiety disorders: a report of 2 meta-analyses. JAMA Psychiatry 2015;72:500-10.
34. Taylor WD. Depression in the elderly. N Engl J Med 2014; 371: 1228-36.
35. Strawn JR, Welge JA, Wehry AM, Keeshin B, Rynn MA. Efficacy and toler-ability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis. Depress Anxiety 2015; 32: 149-57.
36. Gommoll C, Durgam S, Mathews M, et al. A double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorder. Depress Anxiety 2015; 32: 451-9.
37. Mahableshwarkar AR, Jacobsen PL, Serenko M, Chen Y. A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder. Hum Psychopharmacol 2014;29:64-72.
38. Chessick CA, Allen MH, Thase M, et al. Azapirones for generalized anxiety disorder. Cochrane Database Syst Rev 2006; 3:CD006115.
39. Baldwin DS, den Boer JA, Lyndon G, Emir B, Schweizer E, Haswell H. Efficacy and safety of pregabalin in generalised anxiety disorder: a critical review of the literature. J Psychopharmacol 2015; 29: 1047-60.
40. Kreys TJ, Phan SV. A literature review of quetiapine for generalized anxiety disorder. Pharmacotherapy 2015; 35: 175-88.
41. Guaiana G, Barbui C, Cipriani A. Hydroxyzine for generalised anxiety disorder. Cochrane Database Syst Rev 2010; 12:CD006815.
42. Ravindran LN, Stein MB. The pharma-cologic treatment of anxiety disorders: a review of progress. J Clin Psychiatry 2010;71:839-54.
43. Krystal JH, Stossel S, Krystal AD. Restricting benzodiazepines to short-term prescription. JAMA Psychiatry 2015; 72: 734-5.
44. Billioti de Gage S, Pariente A, Bégaud B. Is there really a link between benzodiaz-epine use and the risk of dementia? Expert Opin Drug Saf 2015; 14: 733-47.
45. Hofmann SG, Sawyer AT, Witt AA, Oh D. The effect of mindfulness-based therapy on anxiety and depression: a meta-analytic review. J Consult Clin Psychol 2010;78:169-83.
46. Brenes GA, Danhauer SC, Lyles MF, Hogan PE, Miller ME. Telephone-delivered cognitive behavioral therapy and telephone-delivered nondirective supportive therapy for rural older adults with generalized anxiety disorder: a randomized clinical trial. JAMA Psychiatry 2015; 72: 1012-20.
47. Andrews G, Newby JM, Williams AD. Internet-delivered cognitive behavior therapy for anxiety disorders is here to stay. Curr Psychiatry Rep 2015; 17: 533.
48. Mohatt J, Bennett SM, Walkup JT. Treatment of separation, generalized, and social anxiety disorders in youths. Am J Psychiatry 2014;171:741-8.
49. Wetherell JL, Petkus AJ, White KS, et al. Antidepressant medication augmented with cognitive-behavioral therapy for generalized anxiety disorder in older adults. Am J Psychiatry 2013; 170: 782-9.
50. Bandelow B, Sher L, Bunevicius R, et al. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract 2012; 16: 77-84.
51. Katzman MA, Bleau P, Blier P, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumat-ic stress and obsessive-compulsive disorders. BMC Psychiatry 2014; 14: Suppl 1: S1.